Changes in β-Cell Function and Insulin Sensitivity During Treatment With Dapagliflozin Alone or in Combination With Exenatide in Type 2 Diabetes.

Journal:

Diabetes Care

Published:

2025-07-09

DOI:

10.2337/dc25-0490

Affiliations:

2

Authors:

9

Go to article

Institutions	Authors	Share
The University of Texas Health Science Center at San Antonio (UT Health San Antonio), United States of America (USA)	4.500000	0.50
Texas Diabetes Institute (TDI), University Health System, United States of America (USA)	4.500000	0.50

Interested in Pharmacology and Pharmaceutical Sciences?